Multitumor | PARP Inhibition in Four Common Cancers: Biology, Clinical Research Database and Therapeutic Strategy

44:46
 
Share
 

Manage episode 236056111 series 1464352
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting.

Long description:

Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting. Featuring perspectives from Drs Emmanuel S Antonarakis, Kathleen Moore, Michael J Pishvaian and Melinda Telli.

  • PARP Inhibition as a Therapeutic Strategy — Ovarian Cancer at the Vanguard — Dr Moore (00:00)
  • Current and Emerging Role of PARP Inhibitors in Metastatic Breast Cancer — Dr Telli (8:45)
  • Pancreatic Cancer and PARP Inhibition — What We Know and What We Don’t — Dr Pishvaian (20:45)
  • DNA Repair Deficiency in Advanced Prostate Cancer and the Potential Role of PARP Inhibition — Dr Antonarakis (30:18)

Select publications

2168 episodes available. A new episode about every 0 hours averaging 70 mins duration .